Mirna Therapeutics competitors

Mirna Therapeutics Competitors include Hanger, Advanced Oncotherapy, Affymetrix and Orthofix.
Add company...
Mirna Therapeutics
Mirna Therapeutics researches on and develops miRNA-directed human oncology therapies.
Hanger
Empowering human potential with innovative technologies, efficient and effective clinical solutions, and outstanding customer service.
Advanced Oncotherapy
Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.
Affymetrix
Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell,
Orthofix
Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide.
Founding Date
Founding Date
2007
Founding Date
1861
Founding Date
1994
Founding Date
1994
Founding Date
1980
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Austin, US HQ
Locations
Austin, US HQ
Locations
London, GB HQ
Rolle, CH
Syracuse, US
Locations
Santa Clara, US HQ
Vienna, AT
Shanghai, CN
Singapore, SG
High Wycombe, GB
San Diego, US
see more
Locations
Z.a.i., IT HQ
São Paulo, BR
Willemstad, CW
Arcueil, FR
Ottobrunn, DE
Sona, IT
San Juan, PR
see more
Employees
Employees
369% increase
Employees
4,6004% decrease
Employees
51
Employees
N/A
Employees
938
Valuation ($)
Valuation ($)
261.3 m
Valuation ($)
737.1 m
Valuation ($)
28.9 m
Valuation ($)
N/A
Valuation ($)
1.2 b
Facebook likes
Facebook likes
N/A
Facebook likes
25.8 k
Facebook likes
928
Facebook likes
65 k
Facebook likes
14
Twitter followers
Twitter followers
N/A
Twitter followers
2.4 k
Twitter followers
804
Twitter followers
9.8 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$2.4m (FY, 2017)
Revenue (est.)
$1b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$359.8m (FY, 2015)
Revenue (est.)
$433.8m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$110.8m (FY, 2015)
Cost of goods
$93m (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$249m (FY, 2015)
Gross profit
$340.8m (FY, 2017)
Net income
Net income
($40.4m) (FY, 2017)
Net income
($104.7m) (FY, 2017)
Net income
(£13.7m) (FY, 2017)
Net income
$10.1m (FY, 2015)
Net income
$6.2m (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Hanger
HQ
Austin, US
Employees
4,600↓ 4% decrease

Empowering human potential with innovative technologies, efficient and effective clinical solutions, and outstanding customer service.

View company
Advanced Oncotherapy
HQ
London, GB
Employees
51

Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.

View company
Affymetrix
HQ
Santa Clara, US

Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell,

View company
Orthofix
HQ
Z.a.i., IT
Employees
938

Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide.

View company